GlassScriptPhysician profile
Kristofer J Mitchell
NPI 1205040664
$6,583.12
in general payments reported to CMS, 2019-2025
9 companies · $4,440 in 2025
The $4,440 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $997 · 2020: $11.04 · 2021: $60.48 · 2022: $80.75 · 2023: $126 · 2024: $869 · 2025: $4,440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,750 · Travel and Lodging: $1,021 · Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,750.00 |
| Travel and Lodging | $1,021.37 |
| Food and Beverage | $662.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,008.29 | 2024-2025 | |
| Nuvasive, INC. | $947.07 | 2019 | |
| Abiomed | $154.30 | 2025 | |
| Becton, Dickinson and Company | $145.70 | 2024 | Hemosphere |
| Globus Medical, INC. | $125.62 | 2023 | Independence Mis, Creo 5.5 |
| Boston Scientific Corporation | $80.75 | 2022 | |
| Zimmer Biomet Holdings, INC. | $60.48 | 2021 | |
| Portola Pharmaceuticals, LLC | $48.83 | 2019-2020 | |
| Kls-Martin L.P. | $12.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristofer Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.